FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose
The US Food and Drug Administration (FDA) approved another over-the-counter intranasal naloxone product, marketed as Rextovy, for the emergency treatment of opioid overdose.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.